95 related articles for article (PubMed ID: 7954442)
21. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Goldin LR; Dracopoli NC; Clark WH; Tucker MA
Am J Hum Genet; 1996 May; 58(5):1050-6. PubMed ID: 8651266
[TBL] [Abstract][Full Text] [Related]
22. Genetic basis of susceptibility to melanoma.
Piepkorn MW
J Am Acad Dermatol; 1994 Dec; 31(6):1022-39. PubMed ID: 7962751
[TBL] [Abstract][Full Text] [Related]
23. Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma.
Sini MC; Manca A; Cossu A; Budroni M; Botti G; Ascierto PA; Cremona F; Muggiano A; D'Atri S; Casula M; Baldinu P; Palomba G; Lissia A; Tanda F; Palmieri G
Br J Dermatol; 2008 Feb; 158(2):243-50. PubMed ID: 18028495
[TBL] [Abstract][Full Text] [Related]
24. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
25. Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.
Liu L; Goldstein AM; Tucker MA; Brill H; Gruis NA; Hogg D; Lassam NJ
Genes Chromosomes Cancer; 1997 May; 19(1):52-4. PubMed ID: 9135995
[TBL] [Abstract][Full Text] [Related]
26. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
27. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi.
Indsto JO; Cachia AR; Kefford RF; Mann GJ
Clin Cancer Res; 2001 Dec; 7(12):4054-9. PubMed ID: 11751501
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel deletion Loci at 1p36 and 9p22-21 in melanocytic dysplastic nevi and cutaneous malignant melanomas.
Hussein MR; Roggero E; Tuthill RJ; Wood GS; Sudilovsky O
Arch Dermatol; 2003 Jun; 139(6):816-7. PubMed ID: 12810525
[No Abstract] [Full Text] [Related]
29. Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure.
Briollais L; Chompret A; Guilloud-Bataille M; Bressac-de Paillerets B; Avril MF; Demenais F
Int J Epidemiol; 2000 Jun; 29(3):408-15. PubMed ID: 10869311
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma.
Holland EA; Beaton SC; Edwards BG; Kefford RF; Mann GJ
Oncogene; 1994 May; 9(5):1361-5. PubMed ID: 8152796
[TBL] [Abstract][Full Text] [Related]
31. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children.
Wiecker TS; Luther H; Buettner P; Bauer J; Garbe C
Cancer; 2003 Feb; 97(3):628-38. PubMed ID: 12548604
[TBL] [Abstract][Full Text] [Related]
32. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
33. Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?
Gruis NA; Van der Velden PA; Bergman W; Frants RR
Bull Cancer; 1998 Jul; 85(7):627-30. PubMed ID: 9752270
[TBL] [Abstract][Full Text] [Related]
34. Haplotype analysis limits the position of the familial melanoma locus on 9p to the D9S169-D9S156 interval.
Walker GJ; Nancarrow DJ; Palmer JM; Walters MK; Hayward NK
Melanoma Res; 1994 Feb; 4(1):29-34. PubMed ID: 8032215
[TBL] [Abstract][Full Text] [Related]
35. Exclusion of an extracolonic disease modifier locus on chromosome 1p33-36 in a large Swiss familial adenomatous polyposis kindred.
Plasilova M; Russell AM; Wanner A; Wolf A; Dobbie Z; Müller HJ; Heinimann K
Eur J Hum Genet; 2004 May; 12(5):365-71. PubMed ID: 14735163
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations.
Rizos H; Becker TM; Holland EA; Kefford RF; Mann GJ
Oncogene; 1997 Jul; 15(5):515-23. PubMed ID: 9247305
[TBL] [Abstract][Full Text] [Related]
37. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma.
Gerhard DS; Dracopoli NC; Bale SJ; Houghton AN; Watkins P; Payne CE; Greene MH; Housman DE
Nature; 1987 Jan 1-7; 325(6099):73-5. PubMed ID: 2879249
[TBL] [Abstract][Full Text] [Related]
38. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Begg CB; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Mitra N; Busam K; From L; Berwick M;
J Natl Cancer Inst; 2005 Oct; 97(20):1507-15. PubMed ID: 16234564
[TBL] [Abstract][Full Text] [Related]
39. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
40. Confirmation of chromosome 9p linkage in familial melanoma.
Nancarrow DJ; Mann GJ; Holland EA; Walker GJ; Beaton SC; Walters MK; Luxford C; Palmer JM; Donald JA; Weber JL
Am J Hum Genet; 1993 Oct; 53(4):936-42. PubMed ID: 8213823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
